BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 11734136)

  • 21. [Prognostic factors affecting survival and response in patients with advanced non-small cell lung cancer treated with combination chemotherapy].
    Takifuji N; Fukuoka M; Negoro S; Takada M; Kusunoki Y; Matsui K; Masuda N; Ryu S; Sakai N; Kubota K
    Gan To Kagaku Ryoho; 1990 Mar; 17(3 Pt 2):429-34. PubMed ID: 2157364
    [TBL] [Abstract][Full Text] [Related]  

  • 22. An updated and validated PET/CT volumetric prognostic index for non-small cell lung cancer.
    Finkle JH; Penney BC; Pu Y
    Lung Cancer; 2018 Sep; 123():136-141. PubMed ID: 30089584
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Multicenter analysis of survival and prognostic factors in pathologic stage I non-small-cell lung cancer according to the new 2009 TNM classification.
    León-Atance P; Moreno-Mata N; González-Aragoneses F; Cañizares-Carretero MÁ; García-Jiménez MD; Genovés-Crespo M; Honguero-Martínez AF; Rombolá CA; Simón-Adiego CM; Peñalver-Pascual R
    Arch Bronconeumol; 2011 Sep; 47(9):441-6. PubMed ID: 21676516
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Lymph node type as a prognostic factor for survival in T2 N1 M0 non-small cell lung carcinoma.
    van Velzen E; Snijder RJ; Brutel de la Rivière A; Elbers HR; van den Bosch JM
    Ann Thorac Surg; 1997 May; 63(5):1436-40. PubMed ID: 9146339
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prognostic value of the tissue polypeptide antigen in lung cancer.
    Buccheri G; Ferrigno D
    Chest; 1992 May; 101(5):1287-92. PubMed ID: 1582286
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Diagnostic and prognostic value of serum Cripto-1 in patients with non-small cell lung cancer.
    Xu CH; Chi CZ; Zhang Q; Wang YC; Wang W; Yuan Q; Zhan P; Zhang XW; Lin Y
    Clin Respir J; 2018 Oct; 12(10):2469-2474. PubMed ID: 29570945
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Results after surgery in stage-I bronchogenic carcinoma.
    Wertzel H; Siebert H; Lange W; Swoboda L; Graf E; Hasse J
    Thorac Cardiovasc Surg; 1998 Dec; 46(6):365-9. PubMed ID: 9928860
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Tumor, node and metastasis classification of lung cancer--M1a versus M1b--analysis of M descriptors and other prognostic factors.
    Sánchez de Cos Escuín J; Abal Arca J; Melchor Íñiguez R; Miravet Sorribes L; Núñez Ares A; Hernández Hernández JR; García Arangüena L; Núñez Delgado M; Pavón Fernández MJ; Francisco Corral G; de Esteban Júlvez L; González Budiño MT; Abad Cavaco F; Ansótegui Barrera E; Andreo García F; Serra Mitjans M; Hernández Rodríguez H
    Lung Cancer; 2014 May; 84(2):182-9. PubMed ID: 24629637
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The IASLC Lung Cancer Staging Project: proposals for the inclusion of broncho-pulmonary carcinoid tumors in the forthcoming (seventh) edition of the TNM Classification for Lung Cancer.
    Travis WD; Giroux DJ; Chansky K; Crowley J; Asamura H; Brambilla E; Jett J; Kennedy C; Rami-Porta R; Rusch VW; Goldstraw P;
    J Thorac Oncol; 2008 Nov; 3(11):1213-23. PubMed ID: 18978555
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clinical factors and prognosis in non-small cell lung cancer.
    Martins SJ; Pereira JR
    Am J Clin Oncol; 1999 Oct; 22(5):453-7. PubMed ID: 10521057
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Efficacy and prognostic factors of 178 advanced non-small lung cancer patients undergoing different second-line chemotherapeutic regimens].
    Kong Q; Wang XY; Jiang RC; Ba Y; Li K
    Zhonghua Zhong Liu Za Zhi; 2016 Apr; 38(4):294-9. PubMed ID: 27087377
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prognostic factors affecting survival in non-small cell lung carcinoma patients with malignant pleural effusions.
    Kasapoglu US; Arınç S; Gungor S; Irmak I; Guney P; Aksoy F; Bandak D; Hazar A
    Clin Respir J; 2016 Nov; 10(6):791-799. PubMed ID: 25764010
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prognostic significance of C-reactive protein and smoking in patients with advanced non-small cell lung cancer treated with first-line palliative chemotherapy.
    Koch A; Fohlin H; Sörenson S
    J Thorac Oncol; 2009 Mar; 4(3):326-32. PubMed ID: 19155996
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Analysis of survival in 400 surgically resected non-small cell lung carcinomas: towards a redefinition of the T factor.
    Lyons G; Quadrelli S; Silva C; Vera K; Iotti A; Venditti J; Chertcoff J; Chimondeguy D
    J Thorac Oncol; 2008 Sep; 3(9):989-93. PubMed ID: 18758301
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Impact of chronic obstructive pulmonary disease on the mortality of patients with non-small-cell lung cancer.
    Lee SJ; Lee J; Park YS; Lee CH; Lee SM; Yim JJ; Yoo CG; Han SK; Kim YW
    J Thorac Oncol; 2014 Jun; 9(6):812-7. PubMed ID: 24807154
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [The radiotherapy of inoperable non-small-cell bronchial carcinoma. A retrospective analysis of 427 cases].
    Würschmidt F; Bünemann H; Bünemann C; Beck-Bornholdt HP; Heilmann HP
    Strahlenther Onkol; 1994 May; 170(5):302-4. PubMed ID: 8197553
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Gender influence on weight-loss pattern and survival of nonsmall cell lung carcinoma patients.
    Palomares MR; Sayre JW; Shekar KC; Lillington LM; Chlebowski RT
    Cancer; 1996 Nov; 78(10):2119-26. PubMed ID: 8918405
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prognostic significance of the baseline serum uric acid level in non-small cell lung cancer patients treated with first-line chemotherapy: a study of the Turkish Descriptive Oncological Researches Group.
    Tanriverdi O; Cokmert S; Oktay E; Pilanci KN; Menekse S; Kocar M; Sen CA; Avci N; Akman T; Ordu C; Goksel G; Meydan N
    Med Oncol; 2014 Oct; 31(10):217. PubMed ID: 25216865
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Validation of the 7th TNM classification for non-small cell lung cancer: a retrospective analysis on prognostic implications for operated node-negative cases.
    Bergman P; Brodin D; Lewensohn R; de Petris L
    Acta Oncol; 2013 Aug; 52(6):1189-94. PubMed ID: 23215828
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Survival determinants in extensive-stage non-small-cell lung cancer: the Southwest Oncology Group experience.
    Albain KS; Crowley JJ; LeBlanc M; Livingston RB
    J Clin Oncol; 1991 Sep; 9(9):1618-26. PubMed ID: 1651993
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.